Last update 20 Mar 2025

HLA-A*2402 Restricted Antiangiogenic Peptide Vaccine(Fukushima Medical University)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms
antiangiogenic paptide vaccine
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication-
Inactive Indication
Metastatic hepatocellular carcinoma
Originator Organization
Fukushima Medical UniversityFukushima Medical University
Active Organization-
Inactive Organization
Fukushima Medical UniversityFukushima Medical University
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with HLA-A*2402 Restricted Antiangiogenic Peptide Vaccine(Fukushima Medical University)
NCT01266707
/ Unknown statusPhase 1IIT
Phase 1 Study of HLA-A*2402 Restricted Antiangiogenic Peptide Vaccine Therapy Using Epitope Peptide Derived Feom VEGFR1 and VEGFR2 in Treating Patients With Unresectable, Recurrent, or Metastatic Hepatocellular Carcinoma
100 Clinical Results associated with HLA-A*2402 Restricted Antiangiogenic Peptide Vaccine(Fukushima Medical University)
Login to view more data
100 Translational Medicine associated with HLA-A*2402 Restricted Antiangiogenic Peptide Vaccine(Fukushima Medical University)
Login to view more data
100 Patents (Medical) associated with HLA-A*2402 Restricted Antiangiogenic Peptide Vaccine(Fukushima Medical University)
Login to view more data
100 Deals associated with HLA-A*2402 Restricted Antiangiogenic Peptide Vaccine(Fukushima Medical University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic hepatocellular carcinomaPhase 1
Japan
Fukushima Medical UniversityFukushima Medical University
01 Mar 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free